https://pro.thestreet.com/thefly-newsbreaks/govx-geovax-labs-price-target-adjusted-to-post-reverse-split-at-hc-wainwright
GeoVax Labs price target adjusted to $8 post reverse split at H.C. Wainwright | TheStreet Pro
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's...
https://www.nasdaq.com/press-release/geovax-expands-gedeptinr-patent-portfolio-2025-05-07
GeoVax Expands Gedeptin(R) Patent Portfolio | Nasdaq
ATLANTA, GA- May 7, 2025- GeoVax Labs, Inc., a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious...
patent portfolioexpandsnasdaq
https://pro.thestreet.com/trade-ideas/geovax-labs-sees-rocket-ship-to-the-upside-as-mpox-outbreak-spreads
GeoVax Labs Sees 'Rocket Ship to the Upside' as Mpox Outbreak Spreads | TheStreet Pro
As mpox, formerly "monkey pox," continues to spread around the world, this biotech name has investors looking for an entry point.